基于超声的深度学习影像组学列线图预测新辅助化疗后肿瘤及腋窝淋巴结状态
回顾性纳入2014年10月至2022年7月接受新辅助化疗的243例乳腺癌患者,构建整合临床特征、影像组学与深度迁移学习特征的超声深度学习影像组学列线图(DLRN),用于预测化疗后肿瘤状态及腋窝淋巴结转移。训练队列中DLRN预测肿瘤和淋巴结转移的AUC分别为0.984和0.985,测试队列分别为0.892和0.870;列线图一致性指数训练队列为0.761、测试队列为0.731。Kaplan-Meier生存曲线显示高风险组总生存期显著差于低风险组(P<0.05)。作者认为该模型可能为预测新辅助化疗后肿瘤及淋巴结状态提供临床指导,融合模型还可预测预后。
要点
- 超声DLRN在测试队列预测新辅助化疗后肿瘤状态AUC为0.892、腋窝淋巴结转移AUC为0.870。
- 列线图一致性指数训练队列0.761、测试队列0.731。
- 高风险组总生存期显著差于低风险组(P<0.05)。
核心结论
- 基于超声的DLRN模型可能作为预测乳腺癌患者新辅助化疗后肿瘤及淋巴结状态的临床指导,该融合模型还可预测预后,可能帮助临床医生做出更好的临床决策。
研究设计与样本
- 回顾性纳入2014年10月至2022年7月接受新辅助化疗的243例患者,DLRN整合临床特征及从超声图像提取的影像组学和深度迁移学习特征,通过ROC曲线评估诊断性能、决策曲线分析评估临床实用性,并建立生存模型验证融合算法有效性。
诊断标准与关键数值
- 训练队列中DLRN预测肿瘤的AUC为0.984,预测淋巴结转移的AUC为0.985。
- 测试队列中DLRN预测肿瘤的AUC为0.892,预测淋巴结转移的AUC为0.870。
- 列线图一致性指数训练队列为0.761,测试队列为0.731。
临床应用与阅片要点
- 作者认为该超声DLRN模型可能为预测乳腺癌新辅助化疗后肿瘤及淋巴结状态提供临床指导。
- 作者认为该融合模型可预测患者预后,可能帮助临床医生做出更好的临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aims to explore the feasibility of the deep learning radiomics nomogram (DLRN) for predicting tumor status and axillary lymph node metastasis (ALNM) after neoadjuvant chemotherapy (NAC) in patients with breast cancer. Additionally, we employ a Cox regression model for survival analysis to validate the effectiveness of the fusion algorithm.
MATERIALS AND METHODS: A total of 243 patients who underwent NAC were retrospectively included between October 2014 and July 2022. The DLRN integrated clinical characteristics as well as radiomics and deep transfer learning features extracted from ultrasound (US) images. The diagnostic performance of DLRN was evaluated by constructing ROC curves, and the clinical usefulness of models was assessed using decision curve analysis (DCA). A survival model was developed to validate the effectiveness of the fusion algorithm.
RESULTS: In the training cohort, the DLRN yielded area under the receiver operating characteristic curve values of 0.984 and 0.985 for the tumor and LNM, while 0.892 and 0.870, respectively, in the test cohort. The consistency indices (C-index) of the nomogram were 0.761 and 0.731, respectively, in the training and test cohorts. The Kaplan-Meier survival curves showed that patients in the high-risk group had significantly poorer overall survival than patients in the low-risk group (P < 0.05).
CONCLUSION: The US-based DLRN model could hold promise as clinical guidance for predicting the status of tumors and LNM after NAC in patients with breast cancer. This fusion model can also predict the prognosis of patients, which could help clinicians make better clinical decisions.
引用
- Liu YX, Liu QH, Hu QH, et al. Ultrasound-Based Deep Learning Radiomics Nomogram for Tumor and Axillary Lymph Node Status Prediction After Neoadjuvant Chemotherapy. Acad Radiol. 2024. PMID: 39183131. doi:10.1016/j.acra.2024.07.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。